Lotus Eye Hospital

68.15
+3.87
(6.02%)
Market Cap
141.73 Cr
EPS
1.40
PE Ratio
258.44
Dividend Yield
0.00 %
52 Week High
90.98
52 Week Low
52.35
PB Ratio
2.24
Debt to Equity
0.02
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,129.40
#1 1,09,792.59
102.90
5,584.10
18.77
#1 1,058
-17.46
59.65
6,492.05
93,345.72
71.54
#1 19,165.50
14.74
917
49.14
54.11
671.80
50,718.09
61.76
6,931.20
8.99
645
#1 89.49
62.72
1,673.40
34,197.74
42.51
5,093.40
10.96
790
2.66
65.20
1,213.85
32,602.48
64.67
2,759.20
#1 25.09
326
15.71
53.06
622.50
24,908.65
70.52
2,511.20
12.94
336
20.76
61.44
453.35
22,645.42
83.71
3,723.70
22.85
205
-69.22
62.46
1,378.50
13,998.90
56.82
1,334.00
10.76
218
10.06
59.81
5,180.00
11,456.25
#1 27.61
599.90
11.69
58
8.85
42.49
1,536.85
10,076.51
57.85
1,095.50
21.32
177
20.14
46.80
Growth Rate
Revenue Growth
2.70 %
Net Income Growth
-29.27 %
Cash Flow Change
29.38 %
ROE
-30.65 %
ROCE
-31.28 %
EBITDA Margin (Avg.)
-12.69 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
30
32
35
39
39
42
33
40
48
50
50
Expenses
28
27
31
34
35
37
29
33
40
42
45
EBITDA
3
5
4
5
4
5
4
7
9
8
6
Operating Profit %
7 %
13 %
10 %
11 %
8 %
9 %
11 %
15 %
16 %
14 %
9 %
Depreciation
5
4
3
3
3
3
2
3
3
4
5
Interest
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
-2
0
0
2
1
2
2
4
6
4
1
Tax
-0
-0
0
0
-0
0
0
1
2
1
0
Net Profit
-2
0
0
2
1
1
2
3
4
3
1
EPS in ₹
-0.95
0.05
0.21
0.84
0.34
0.51
0.75
1.44
1.96
1.40
0.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
56
55
55
58
57
58
59
62
63
67
Fixed Assets
47
44
41
43
44
43
41
44
44
49
Current Assets
5
6
7
8
7
11
14
13
15
14
Capital Work in Progress
0
0
1
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
9
11
13
15
12
15
19
18
19
18
Total Liabilities
56
55
55
58
57
58
59
62
63
67
Current Liabilities
6
5
4
7
6
6
6
6
5
6
Non Current Liabilities
1
1
1
1
1
1
1
1
0
1
Total Equity
49
50
50
51
50
51
53
55
58
59
Reserve & Surplus
29
29
29
30
29
31
32
34
37
39
Share Capital
21
21
21
21
21
21
21
21
21
21

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
2
2
0
-1
4
3
-1
1
-2
Investing Activities
-5
-1
-1
-4
-4
-1
1
-4
-2
-5
Operating Activities
2
3
3
6
4
5
3
4
4
6
Financing Activities
2
-1
-0
-2
-1
0
-0
-2
-2
-3

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
57.74 %
57.74 %
57.74 %
57.74 %
57.74 %
57.74 %
57.88 %
58.14 %
58.17 %
58.43 %
57.58 %
56.58 %
41.40 %
40.24 %
40.03 %
40.14 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.03 %
0.04 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
27.31 %
26.49 %
27.51 %
26.23 %
26.95 %
27.13 %
23.13 %
21.79 %
21.63 %
21.14 %
22.95 %
24.07 %
42.47 %
43.82 %
42.84 %
41.73 %
Others
14.95 %
15.77 %
14.75 %
16.03 %
15.31 %
15.13 %
18.99 %
20.07 %
20.21 %
20.43 %
19.48 %
19.34 %
16.13 %
15.93 %
17.10 %
18.09 %
No of Share Holders
5,963
6,330
6,175
6,226
6,830
7,031
7,416
7,416
7,345
7,425
7,660
8,314
12,502
11,759
12,514
11,734

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.5 0.5 0.00 0.00 0.5 0.5 0.00 0.00 0.00
Dividend Yield (%) 0.00 1.81 2.27 0.00 0.00 0.94 0.87 0.00 0.00 0.00

Corporate Action

Announcements

Closure of Trading Window3 days ago
Integrated Filing (Financial)Feb 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Financial Results For The Quarter Ended 31.12.2024Feb 12, 2025
Outcome Of Board Meeting Held On 12.02.2025Feb 12, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Announcement under Regulation 30 (LODR)-Change in RTAJan 02, 2025
Closure of Trading WindowDec 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Results For The Quarter Ended 30Th September 2024Nov 12, 2024
Board Meeting Outcome for Outcome Of Board MeetingNov 12, 2024
Board Meeting Intimation for Consideration Of Unaudited Standalone Financial Results For The Half Year And Period Ended September 30Th 2024Nov 04, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 10, 2024
Closure of Trading WindowSep 26, 2024
Announcement under Regulation 30 (LODR)-CessationSep 25, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Sep 05, 2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Aug 28, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 20, 2024
Voting Results Of 27Th Annual General MeetingAug 14, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 13, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2024
Outcome Of Board MeetingAug 12, 2024
Outcome Of Board MeetingAug 12, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 23, 2024
Reg. 34 (1) Annual Report.Jul 22, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 22, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 08, 2024
Closure of Trading WindowJun 28, 2024
Inauguration Of New Center Of Lotus Eye Hospital And Institute Limited At Karur TamilnaduJun 12, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 28, 2024
Financial Results For The Quarter And Year Ended 31St March 2024May 27, 2024
Outcome Of Board Meeting Held On 27Th May 2024May 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 22, 2024
Re-revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.May 03, 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 20, 2024
Certificate Under Regulation 40(9) Of SEBI LODR 2015Apr 16, 2024
Compliance Certificate Under Regulation 7(3) Of SEBI LODR 2015Apr 06, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 05, 2024
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011Apr 04, 2024
Closure of Trading WindowMar 29, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 16, 2024
Outcome Of Board Meeting Held On February 14Th 2024Feb 14, 2024
Outcome Of Board MeetingFeb 14, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jan 08, 2024
Announcement under Regulation 30 (LODR)-Change in RTAJan 03, 2024
Imposition Of Penalty Under SEBI (Prohibition Of Insider Trading) Regulations 2015Dec 29, 2023
Closure of Trading WindowDec 28, 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Dec 23, 2023
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Dec 22, 2023

Technical Indicators

RSI(14)
Neutral
60.92
ATR(14)
Less Volatile
5.14
STOCH(9,6)
Neutral
67.44
STOCH RSI(14)
Neutral
75.16
MACD(12,26)
Bullish
1.41
ADX(14)
Weak Trend
16.17
UO(9)
Bearish
55.32
ROC(12)
Uptrend And Accelerating
17.68
WillR(14)
Neutral
-23.69